[{"NetIncomeLoss_1_Q2_USD":1189000000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"Depreciation_2_Q2_USD":795000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-686000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":645000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-9066000000.0,"TreasuryStockCommonShares_0_Q2_shares":209736139.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":3118000000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":91000000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q2_USD":-5230000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RepaymentsOfLongTermDebt_2_Q2_USD":5000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1900000000.0,"AociLossCashFlowHedgeCumulativeGainLossAfterTax_0_Q2_USD":-98000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":947000000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":31000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-371000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":103000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":165000000.0,"PaymentsForOtherTaxes_2_Q2_USD":715000000.0,"CommonStockSharesIssued_0_Q2_shares":1982553488.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":2720000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2694000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":9348000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4947000000.0,"ContractWithCustomerLiability_0_Q2_USD":406000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q2_USD":6000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_2_Q2_USD":118000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":2726000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":5509000000.0,"LongTermDebtCurrent_0_Q2_USD":755000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":14076000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":14369000.0,"AssetsCurrent_0_Q2_USD":22627000000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":-10000000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-259000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":796000000.0,"EquityMethodInvestments_0_Q2_USD":260000000.0,"AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0_Q2_USD":3738000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":79000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":140000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1793279000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1792418000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":1189000000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":2982000000.0,"MinorityInterest_0_Q2_USD":229000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":2000000000.0,"EarningsPerShareBasic_1_Q2_USD":0.67,"EarningsPerShareBasic_2_Q2_USD":1.67,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":15100000000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":654000000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":1308000000.0,"ShortTermInvestments_0_Q2_USD":286000000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-48000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":6113000000.0,"TreasuryStockCommonValue_0_Q2_USD":10340000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":409000000.0,"NumberOfReportableSegments_1_Q2_segment":4.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":8658000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1013000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":1408000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":2862000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":1184000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":2969000000.0,"IncreaseDecreaseInInventories_2_Q2_USD":542000000.0,"CostsAndExpenses_1_Q2_USD":8831000000.0,"CostsAndExpenses_2_Q2_USD":17178000000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":758000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-2231000000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-3000000.0,"ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_2_Q2_USD":48000000.0,"CommonStockValue_0_Q2_USD":24153000000.0,"NumberOfReportableSegments_2_Q2_segment":4.0,"IncomeTaxExpenseBenefit_1_Q2_USD":159000000.0,"Assets_0_Q2_USD":73269000000.0,"ShareBasedCompensation_2_Q2_USD":420000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":1.0,"InterestExpense_2_Q2_USD":269000000.0,"PaymentsForProceedsFromInvestments_2_Q2_USD":-81000000.0,"LiabilitiesCurrent_0_Q2_USD":12614000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1779203000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1778049000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1525000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":4765000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":1348000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":3391000000.0,"Goodwill_0_Q2_USD":23485000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":219000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-120000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":10258000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1900000000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":-279000000.0,"InterestExpense_1_Q2_USD":134000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1900000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":8658000000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":103000000.0,"NetIncomeLoss_2_Q2_USD":2982000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8816000000.0,"ShortTermBorrowings_0_Q2_USD":199000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q2_USD":2000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2_Q2_USD":48000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":34029000000.0,"DerivativeFairValueOfDerivativeAsset_0_Q2_USD":284000000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":1603000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.66,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":1.66,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":13681000000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":242000000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":5354000000.0,"LongTermDebtNoncurrent_0_Q2_USD":17547000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-28000000.0,"EarningsPerShareDiluted_1_Q2_USD":0.66,"EarningsPerShareDiluted_2_Q2_USD":1.66,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-200000000.0,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":27800000000.0,"DeferredIncomeTaxesAndOtherAssetsNoncurrent_0_Q2_USD":3855000000.0,"InvestmentIncomeInterest_1_Q2_USD":11000000.0,"InvestmentIncomeInterest_2_Q2_USD":22000000.0,"InventoryNet_0_Q2_USD":5439000000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":746000000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":310000000.0,"AccountsPayableTradeCurrent_0_Q2_USD":4017000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":101000000.0,"OperatingIncomeLoss_1_Q2_USD":1392000000.0,"OperatingIncomeLoss_2_Q2_USD":3501000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":20679000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":10223000000.0,"CommonStockSharesAuthorized_0_Q2_shares":2400000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2_Q2_USD":36000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q2_USD":18000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":73269000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1248000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1820000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":29053000000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.67,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":1.67,"LongTermInvestments_0_Q2_USD":805000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":498000000.0,"ProceedsFromRepaymentsOfShortTermDebt_2_Q2_USD":20000000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-133000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":810000000.0,"DividendsPayableCurrent_0_Q2_USD":799000000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":9000000.0,"DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_0_Q2_USD":80000000.0,"ProfitLoss_2_Q2_USD":2982000000.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_2_Q2_USD":-83000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":19074000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"StockholdersEquity_0_Q2_USD":33800000000.0,"EntityCommonStockSharesOutstanding_0_Q2_shares":1772817349.0,"Ticker":"ABT","CIK":"1800","name":"ABBOTT LABORATORIES","OfficialName":"Abbott Laboratories Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"211582602395.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"SP500","filed":"20210804"}]